Andreas Gerloff
Bayer AG
Global Head of Medical Customer Excellence
The Future of Medical Communication: Embracing Omnichannel
- Exploring the transformative world of omnichannel communication within global and local medical affairs.
- Discussing strategies and requirements necessary for implementing an effective omnichannel approach.
- Addressing the importance of data and cross-functional communication to refine and personalize communication methods, enhancing impact on the target audience.
- Highlighting methods to tailor content and messaging to meet the diverse preferences of various healthcare professionals and stakeholders.
Olga Andreeva
Novo Nordisk
Global Medical Excellence Director
Activating Insights in Medical Affairs: Navigating the Rare Disease Landscape
- Navigating the Rare Disease Landscape: Maximizing impact where patient and specialist numbers are limited, emphasizing the importance of each contribution to the insights process.
- Comprehensive Insights Generation: Combining field insights with diverse sources — no detail is too small to be valuable in the rare disease space.
- Efficient Insights Analysis: Tailoring analysis to volume—manual validation for low, inconsistent input, with AI support as data scales up.
- Delivering Actionable Insights: Providing high-quality insights that influence team tactics and overall strategy, with medical becoming an invaluable partner in co-creating the full insights picture. By collaborating with other teams, medical co-delivers on the core insights narrative, shaping strategy across the organization.
- Leveraging Insights for Future Engagement: Using insights to inform future interactions and strategies with external stakeholders and customers.
Piotr R. Wlodarczyk
BieGene
Medical Director
The Future of Medical Affairs: Equal footing with R&D and Commercial
- In the past- supporting function
- Currently - at the transition
- In forthcoming future - strategic partner
- Examples from recent launches
- Barriers during transformations and drivers for development
Michael Zaiac
Daiichi Sankyo Europe GmbH
Head, Medical Affairs, Oncology Europe and Canada
Reinventing Medical Affairs in the era of Big Data & Analytics
- Leveraging the power of data and technology for improving outcomes, advancing patient care & driving innovation
- Integration of data-driven strategies into Medical Affairs - not just a trend but a necessity in today's complex healthcare landscape
- Building a data & analytics strategy roadmap to enhance efficiency and outcomes: Governance, quality, storage, standardization and advanced analytics
Catarina Santos
Novartis Pharma AG
Executive Director, Launch Medical IM Europe
Increasing role of Medical Affairs in driving product launch strategy
- Medical Affairs in the Driver’s Seat for Launch Excellence
- Leveraging data-driven insights and experience to optimize launch support strategies
- Future avenues and key challenges for launch excellence
Sandra Casiano
Sanofi Genzyme
Senior Global Medical Director
Next generation of Medical Affairs - eclipsed by the coming era of patient-centric healthcare
- Advancing Medical Affairs to be a Value Based Strategic Partner
- Embracing Digital Technologies and Patient-Centred Care
- Navigating AI, omnichannel, and digital health
The role of Medical Affairs has evolved from a primarily scientific support function to a dynamic, patient-centric, and data-driven discipline. With advancements in digital health, global expansion, and the emphasis on value-based care, Medical Affairs professionals now navigate a complex landscape, collaborating cross-functionally and advocating for evidence-based medicine. Join us as we continue to explore how to bridge the gap between science and commercial objectives and ensure that safe, effective, and patient-centered healthcare products remain paramount in an ever-changing healthcare environment.